Note 3 - Selected Balance Sheet Data (Tables)
|
6 Months Ended |
Dec. 31, 2019 |
|---|
| Notes Tables |
|
| Schedule of Inventory, Current [Table Text Block] |
| |
|
December 31, |
|
|
June 30, |
|
| |
|
2019 |
|
|
2019 |
|
| Raw materials |
|
$ |
44,353 |
|
|
$ |
40,913 |
|
| Finished goods(1) |
|
|
54,502 |
|
|
|
53,376 |
|
| Inventories, net |
|
$ |
98,855 |
|
|
$ |
94,289 |
|
|
| Property, Plant and Equipment [Table Text Block] |
| |
|
December 31, |
|
|
June 30, |
|
| |
|
2019 |
|
|
2019 |
|
| Land |
|
$ |
7,561 |
|
|
$ |
7,065 |
|
| Buildings and improvements |
|
|
179,164 |
|
|
|
175,019 |
|
| Machinery and equipment |
|
|
139,814 |
|
|
|
124,233 |
|
| Property and equipment, cost |
|
|
326,539 |
|
|
|
306,317 |
|
| Accumulated depreciation |
|
|
(162,226 |
) |
|
|
(152,278 |
) |
| Property and equipment, net |
|
$ |
164,313 |
|
|
$ |
154,039 |
|
|
| Schedule of Intangible Assets and Goodwill [Table Text Block] |
| |
|
December 31, |
|
|
June 30, |
|
| |
|
2019 |
|
|
2019 |
|
| Developed technology |
|
$ |
436,454 |
|
|
$ |
435,679 |
|
| Trade names |
|
|
147,514 |
|
|
|
147,296 |
|
| Customer relationships |
|
|
214,434 |
|
|
|
214,320 |
|
| Patents |
|
|
2,309 |
|
|
|
2,133 |
|
| Intangible assets |
|
|
800,711 |
|
|
|
799,428 |
|
| Accumulated amortization |
|
|
(250,999 |
) |
|
|
(219,999 |
) |
| Intangible assets, net |
|
$ |
549,712 |
|
|
$ |
579,429 |
|
|
| Schedule of Finite-Lived Intangible Assets [Table Text Block] |
| Beginning balance |
|
$ |
579,429 |
|
| Acquisitions |
|
|
- |
|
| Other additions |
|
|
189 |
|
| Amortization expense |
|
|
(30,108 |
) |
| Currency translation |
|
|
202 |
|
| Ending balance |
|
$ |
549,712 |
|
|
| Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] |
| 2020 remainder |
|
$ |
31,164 |
|
| 2021 |
|
|
60,162 |
|
| 2022 |
|
|
57,848 |
|
| 2023 |
|
|
55,976 |
|
| 2024 |
|
|
53,416 |
|
| Thereafter |
|
|
291,146 |
|
| Total |
|
$ |
549,712 |
|
|
| Schedule of Goodwill [Table Text Block] |
| |
|
Protein Sciences |
|
|
Diagnostics and Genomics |
|
|
Total |
|
| Beginning balance |
|
$ |
377,407 |
|
|
|
355,260 |
|
|
$ |
732,667 |
|
| Acquisitions (Note 4) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Currency translation |
|
|
1,609 |
|
|
|
(35 |
) |
|
|
1,574 |
|
| Ending balance |
|
$ |
379,016 |
|
|
$ |
355,225 |
|
|
$ |
734,241 |
|
|